Cardiovascular Innovations 2027: The Operators Enclave

Cardiovascular Innovations 2027: The Operators Enclave

Overview

CVI 2027 is a world-class meeting focused on state-of-the-art therapy for peripheral, coronary, and structural heart disease.

JULY 30-August 1, 2027

JW Marriott Downtown Austin, TX

Cardiovascular Innovations 2027: The Operators Enclave(TM) is a world-class meeting focused on state-of-the-art therapy for peripheral, coronary, and structural heart disease. The conference features:

  • Highly interactive expert discussions focused on professional experiences
  • An emphasis on the latest innovations in interventional cardiovascular care
  • Live case transmissions by the world's leading operators in the United States and Europe
  • Satellite symposia and hands-on workshops

TARGET AUDIENCE

Cardiovascular Innovations 2027: The Operators Enclave(TM) is designed to meet the needs of cardiologists, surgeons, internists, trainees, investigators, nurses, nurse practitioners, physician assistants and allied health care staff who participate in the care of patients with coronary, peripheral, and structural cardiovascular diseases. The focus of the conference is on innovative health care solutions for these patients.

ABOUT CARDIOVASCULAR INNOVATIONS FOUNDATION

Cardiovascular disease is the number one cause of death globally, accounting for nearly 20.5 million deaths each year (2025 NIH estimate). Cardiovascular disease may strike those in their prime years and, due to population aging, also afflict elderly people who are otherwise living healthy lives. Improvements in cardiovascular therapy have markedly reduced procedural risk, and thereby enabled the treatment of a broad range of patients, more than ever before in the history of medicine. Nonetheless, significant disparities in the delivery of cardiovascular care continue to exist, leading to large unmet clinical needs for many patients worldwide. Innovation in the delivery of cardiovascular care, as well as education of the public at-large, is essential for optimizing the management of these patients.

The Cardiovascular Innovations Foundation is organized and operated exclusively for charitable, scientific, and educational purposes within the meaning of Section 501(c)(3) of the Internal Revenue Code.

The mission of the Foundation is to address unmet needs in cardiovascular care through the study, design, and development of innovative health care solutions and education of health care providers and the larger public.

BOARD OF DIRECTORS

Subhash Banerjee, MD, FACC, FSCAI
Baylor Heart and Vascular Hospital, Dallas, TX

Emmanouil S. Brilakis, MD, PhD, FACC, FAHA, FSCAI, FESC
Minneapolis Heart Institute at Abbott Northwestern Hospital

Mehdi H. Shishehbor, DO, MPH, PhD, FACC, FAHA, FSCAI
University Medical Partners Interventional and Endovascular, Stanford Medical Partners

Paul Sorajja, MD, FACC, FAHA, FSCAI
Banner Health Institute, Phoenix, AZ

Good to know

Highlights

  • 2 days 6 hours
  • In person

Refund Policy

Refunds up to 7 days before event

Location

JW Marriott Austin

110 East 2nd Street

Austin, TX 78701

How do you want to get there?

Map
Frequently asked questions
Organized by
Report this event

More events from Cardiovascular Innovations Foundation

Discover more events from Cardiovascular Innovations Foundation, from Science & Tech to other experiences you might love.

Still looking for the right event?

Explore all events in Austin and filter by date, category, and more to find the perfect fit.